1- Pregnancy and / or breastfeeding (pregnancy test should be performed at the time of entry). 2- Previous antirretroviral treatment or current criteria for antirretroviral therapy treatment (<350 CD4 + T cells / mm3). 3- Post-menopausal women (age 45 or older with at least two years of amenorrhea) or documented history of hysterectomy and / or annexectomy double sex. 4- Known history of allergies or drug, or to any component of the formulations studied (at the discretion of the investigator) hypersensitivity. 5- Refer viral disease in the last 7 days. 6- To be ingesting some medication 15 days (or for 5 half-lives) before the first dose of product research or nonprescribed or free drugs (OTC drugs) or herbal medicines / dietary supplements in a period seven days before the first dose of research products until the end of the study. 7- Serum creatinin values higher than 1.5 times the upper limit of the reference range. 8- Values of AST and ALT higher than 2 times the upper limit of the reference range. 9- Positive for hepatitis B and C and serology results. 10- History of alcoholism in the past 6 months (not less consumption ¼ bottle of rum or one (1) bottle of wine or three (3) beers in a higher frequency of twice a week. 11- Patients with a history of drug consumption dependence or drug abuse. 12- To be undergone major surgery within 6 months prior to baseline.